The results suggest that a balanced level of STARD10 is important for regulating the proliferative activity in breast cancer and its dysregulation in either direction (increase or decrease) leads to an increase in cell proliferation and migration with consequent increase in neoplastic progression. Here, STARD10 is linked to breast cancer.